Exploring Emotion and Emotional Variability as Digital Biomarkers in Frontotemporal Dementia Speech

Frontotemporal Dementia (FTD) encompasses a range of progressive neurodegenerative conditions that impair speech production and comprehension, higher cognitive functions, behavior, and motor skills. Considerable research has focused on conventional acoustic speech markers in FTD, as well as assessments of apathy and challenges in emotion recognition and expression.

In this study, Redenlab has collaborated with the University of Melbourne, Monash University, and the Massachusetts Institute of Technology.

For more information about the study, please click here.

Related Post

  • Posted on 19 November, 2024
    Functional magnetic resonance imaging (fMRI) offers valuable insights into how the brain controls motor speech functions. However, there are still...
    • Posted on 12 November, 2024
      Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for Ataxia Research...
      • Posted on 31 October, 2024
        Remote speech tests can complement in-clinic exams to help guide treatment for Multiple Sclerosis (MS). Previous studies suggested that speech...